Larotrectinib Market Witnesses Strong Growth as Precision Oncology Transforms Global Cancer Treatment

https://growthmarketreports.co....m/report/larotrectin

The Larotrectinib Market is experiencing significant growth as precision oncology continues to reshape modern cancer care. Larotrectinib is a targeted therapy developed for patients with tumors harboring neurotrophic tyrosine receptor kinase (NTRK) gene fusions, regardless of cancer type. According to Growth Market Reports, the market is expected to expand steadily as personalized medicine gains wider acceptance worldwide.

Larotrectinib Market Size to Hit USD 3185.64 Million by 2034 | CAGR 22.9%
growthmarketreports.com

Larotrectinib Market Size to Hit USD 3185.64 Million by 2034 | CAGR 22.9%

Global Larotrectinib market reached USD 498 million in 2025, projected to grow at 22.9% CAGR through 2034, driven by precision oncology adoption.